Unlock instant, AI-driven research and patent intelligence for your innovation.

Lipase derived from pseudomonas and application of lipase

A technology of Pseudomonas and lipase, which is applied in the field of lipase derived from Pseudomonas and its application, can solve the problems of not meeting the high optical purity requirements of drugs, low optical purity, etc., and achieve the improvement of ee value and high optical purity. The effect of purity

Pending Publication Date: 2021-02-02
江苏美科生物科技有限公司 +1
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the study found that the optical purity of the reaction product is relatively low under the existing conditions, which does not meet the high optical purity requirements of drugs
And the existing lipase prepares pregabalin key intermediate (S)-3-(2-methoxyl-2- Oxoethyl)-5-methylhexanoic acid, the optical purity (ee value) of the product is relatively low, such as when using novazyme435 enzyme, the ee value is 76%

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lipase derived from pseudomonas and application of lipase
  • Lipase derived from pseudomonas and application of lipase
  • Lipase derived from pseudomonas and application of lipase

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Example 1: Cloning of wild-type lipase derived from Pseudomonas

[0025] Design a pair of primers psu-F: 5'-CATATGGTTCAGATTCAGGG-3';

[0026] psu-R:5'-CTCGAGTACAGACATGTACC-3';

[0027] The polymerase chain reaction (PCR reaction) was carried out with Pseudomonas species as the starting strain template. Pseudomonas was purchased from the China General Microorganism Culture Collection and Management Center, numbered Pseudomonas CGMCC No.4184. PCR reaction system: 18μL of redistilled water, 2.5μL of PCR buffer, 1μL of magnesium chloride (25mM concentration), 1.5μL of dNTP (2.5mM concentration), 0.5μL of the above two primers, 20ng of the above template, 2 units of Taq enzyme (Shanghai Sangon Company).

[0028]PCR conditions: denaturation at 94°C for 10 minutes, denaturation at 94°C for 30 seconds, annealing at 55°C for 30 seconds, extension at 72°C for 1 minute and 15 seconds, a total of 30 cycles, and a final extension at 72°C for 10 minutes.

Embodiment 2

[0029] Example 2: Plasmid construction containing lipase gene

[0030] After the PCR amplification reaction, use 1% agarose gel to perform nucleotide electrophoresis with a voltage of 100 volts. After the band clearly appears, perform gel tapping on the target band with a size of about 1200 bp, and use the gel to recover The target DNA fragment was recovered by the kit (Takara Bio Co., Ltd.), and then the obtained DNA fragment and the vector pET24a+ (Novagen Co., Ltd.) were combined according to the method described in the 2009 version of the product catalogue of Takara Bio Co., Ltd. (website: www.takara.com.cn). Double digestion with restriction enzymes NdeI and XhoI.

[0031] The digested products were again subjected to DNA electrophoresis at a voltage of 100 volts, and fragments and vectors with corresponding sizes of about 1000 bp and 5300 bp were recovered. Finally, after mixing the fragments and vectors in a ratio of 3:1, 1.5 units of T4 ligase were added, and the tempe...

Embodiment 3

[0033] Example 3: Construction of genetically engineered bacteria expressing lipase

[0034] With calcium chloride transformation method (edited by Hao Fuying et al, "Molecular Biology Experimental Technology", Peking University Press, 1998, p. 12-15) the recombinant plasmid finally obtained in Example 2 was transformed into E.coli BL21 ( DE3) (Novagen Company), namely obtain the lipase Escherichia coli expression strain.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of lipase derived from pseudomonas in preparation of a pregabalin key chiral intermediate (S)-3-(2-methoxy-2-oxoethyl)-5-methylcaproic acid. The lipase mutant derived from the pseudomonas is used for catalyzing hydrolysis reaction of a substrate 3-(2-methylpropyl)diethyl glutarate to obtain (S)-3-(2-methoxy-2-oxoethyl)-5-methylcaproic acid, and the ee value is larger than 99%. The (S)-3-(2-methoxy-2-oxoethyl)-5-methylcaproic acid with high optical purity is fully produced and prepared by the enzyme method.

Description

technical field [0001] The invention belongs to the technical field of bioengineering, in particular to a lipase derived from Pseudomonas and its application. Background technique [0002] Pregabalin (trade name: Pregabalin) ) is produced by Pfizer, the chemical name is S-(+)-3-aminomethyl-5-methylhexanoic acid, and the structural formula is shown in (1). [0003] [0004] In July 2004, it was approved by the European Union for the treatment of partial epilepsy, and it was approved by the US FDA in 2005 for the relief and treatment of neuropathic pain, including diabetic peripheral neuropathy neuralgia (DPN), post-herpetic neuralgia (PHN). ), spinal cord injury-related neuralgia, fibromyalgia-related neuralgia, and partial-onset seizures in patients 4 years of age and older. Pregabalin was the first FDA-approved drug for diabetic peripheral neuropathy and post-herpetic neuralgia, and is currently the best-selling analgesic. Worldwide, several pharmaceutical companies ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N9/20C12N15/55C12N15/70C12P7/62
CPCC12N9/20C12N15/70C12P7/62C12Y301/01003
Inventor 余宏陈涛王波钱晓东
Owner 江苏美科生物科技有限公司